Human Complement Factor B ELISA Kit (with Controls)

$500.00

Catalog Number: EF7001-8

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Sandwich ELISA

Entrez Gene

629

Components

Biotinylated Human Complement Factor B Antibody, Chromogen Substrate (1x), EIA Diluent Concentrate (10x), Human Complement Factor B Microplate, Human Complement Factor B Standard, Low Control, Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

1.35 ng/ml

Range

2.188 – 140 ng/ml

Samples Type

CSF, Milk, Plasma, Saliva, Serum

Associated Disease

Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Species

Human

UniProt

P00751

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications citing Assaypro: Human Complement Factor B ELISA Kit ... (10 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis

Complement system abnormalities in patients with atypical hemolytic uremic syndrome and catastrophic antiphospholipid syndrome

  • http://vestnikramn.spr-journal.ru/jour/article/view/769
  • KA Demyanova, NL Kozlovskaya… - Annals of the …, 2017 - vestnikramn.spr-journal.ru
  • Background: The role of the alternative complement pathway (AP) abnormalities in the pathogenesis of aHUS is well studied. Clinical and morphological manifestations of atypical HUS …

The alternative complement pathway in ANCA associated vasculitis: further evidence and a meta analysis. Clin Exp Immunol. 202(3):394-402.

Lymphatic Filariasis: Host and parasite factors and the pathogenesis of systemic adverse events following treatment

Utility of plasma exchange in early recurrent C3 glomerulopathy

Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis

Renal and Pulmonary Dense Deposit Disease Presenting as Pulmonary-Renal Syndrome

Changes in the complement system in membranoproliferative glomerulonephritis

Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome and Catastrophic Antiphospholipid Syndrome

Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer

Loading data...